Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

Name: Bicara Therapeutics Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Bicara Therapeutics·Business Segments·1 segment·Rolls up to Pre-Tax Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$36.77M	-$27.34M	-$36.29M	-$37.33M	-$56.16M
Total	-$36.77M	-$27.34M	-$36.29M	-$37.33M	-$56.16M

Segments

Business SegmentsView metric